A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor.
Extending survival in meningioma patients with innovative radiopharmaceutical therapy
- Post author:
- Post published:September 29, 2024
- Post category:uncategorized